USANA Health Sciences, Inc.USNANYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank0
3Y CAGR-55.0%
5Y CAGR-43.3%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-55.0%/yr
vs -9.7%/yr prior
5Y CAGR
-43.3%/yr
Recent deceleration
Acceleration
-45.3pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $8.53M | -83.3% |
| 2024 | $50.92M | -9.3% |
| 2023 | $56.15M | -40.0% |
| 2022 | $93.50M | -13.8% |
| 2021 | $108.46M | -25.4% |
| 2020 | $145.31M | +31.9% |
| 2019 | $110.16M | -21.7% |
| 2018 | $140.69M | +27.2% |
| 2017 | $110.56M | +6.0% |
| 2016 | $104.33M | - |